Department of Endocrinology and Metabolism, Kanazawa University Graduate School of Medical Sciences, Kanazawa, Japan.
Antioxid Redox Signal. 2020 Sep 1;33(7):517-524. doi: 10.1089/ars.2020.8087. Epub 2020 May 27.
Selenoprotein P functions as a redox protein through its intrinsic thioredoxin domain and by distributing selenium to intracellular glutathione peroxidases, that is, glutathione peroxidase 1 and 4. : Selenoprotein P was rediscovered as a hepatokine that causes the pathology of type 2 diabetes and aging-related diseases, including exercise resistance in the skeletal muscle, insulin secretory failure in pancreatic β cells, angiogenesis resistance in vascular endothelial cells, and myocardial ischemicreperfusion injury. It was unexpected for the antioxidant selenoprotein P to cause insulin resistance, because oxidative stress associated with obesity and fatty liver is a causal factor for hepatic insulin resistance. : Oxidative stress induced by the accumulation of reactive oxygen species (ROS) has a causal role in the development of insulin resistance, whereas ROS themselves function as intracellular second messengers that promote insulin signal transduction. ROS act both positively and negatively in insulin signaling depending on their concentrations. It might be possible that selenoprotein P causes "reductive stress" by eliminating a physiological ROS burst that is required for insulin signal transduction, thereby causing insulin resistance. In a large-scale intervention study, selenium supplementation that upregulates selenoprotein P was paradoxically associated with an increased risk for diabetes in humans. This review discusses the molecular mechanisms underlying the selenoprotein P-mediated resistance to angiogenesis and to exercise. : Selenoprotein P may be the first identified intrinsic factor that induces reductive stress, causing resistance to intracellular signal transduction, which may be the therapeutic target against sedentary-lifestyle-associated diseases, such as diabetes and obesity.
硒蛋白 P 通过其内在的硫氧还蛋白结构域和将硒分配到细胞内谷胱甘肽过氧化物酶(即谷胱甘肽过氧化物酶 1 和 4)的功能发挥作为一种氧化还原蛋白。硒蛋白 P 被重新发现为一种肝源细胞因子,可导致 2 型糖尿病和与衰老相关的疾病的病理学,包括骨骼肌运动抵抗、胰腺β细胞胰岛素分泌衰竭、血管内皮细胞血管生成抵抗和心肌缺血再灌注损伤。抗氧化硒蛋白 P 会引起胰岛素抵抗,这令人意外,因为与肥胖和脂肪肝相关的氧化应激是肝胰岛素抵抗的一个因果因素。由活性氧(ROS)积累引起的氧化应激在胰岛素抵抗的发展中起因果作用,而 ROS 本身作为细胞内第二信使,促进胰岛素信号转导。ROS 在胰岛素信号传导中既起积极作用也起消极作用,这取决于它们的浓度。硒蛋白 P 通过消除胰岛素信号转导所需的生理性 ROS 爆发,从而引起胰岛素抵抗,从而可能引起“还原性应激”。在一项大规模干预研究中,上调硒蛋白 P 的硒补充剂与人类糖尿病风险增加呈矛盾相关。本综述讨论了硒蛋白 P 介导的抗血管生成和运动抵抗的分子机制。硒蛋白 P 可能是第一个被确定的内在因素,它会引起还原性应激,导致细胞内信号转导抵抗,这可能是针对与久坐生活方式相关的疾病(如糖尿病和肥胖症)的治疗靶点。